Sign In
Buy BCEL
$0.0900
+0 (+0%)
At Close: Sep 13, 2024
Atreca to Present at the Cowen and Company 40th Annual Health Care Conference
09:30pm, Monday, 24'th Feb 2020
SOUTH SAN FRANCISCO, Calif., Feb. 24, 2020 -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique.
2 Biotech Stocks Poised for Jaw-Dropping Gains
09:00pm, Sunday, 23'rd Feb 2020
These relative newcomers to the landscape of publicly-traded biotech stocks could be big winners for early shareholders.
Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of ATRC-101 in Patients with Select Solid Tumors
09:30pm, Thursday, 13'th Feb 2020
Atreca, Inc. (Atreca) (BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response,
Atreca Announces Strategic Research Collaboration with Merck to Identify Novel Antibody Targets in Oncology
09:05pm, Wednesday, 05'th Feb 2020
Atreca, Inc. (Atreca) (BCEL), a biotechnology company focused on the development of novel cancer therapeutics generated through a unique discovery platform based on interrogation of the active human i
These new Bay Area stocks from 2019 are 'underwater' as year ends
03:48pm, Thursday, 26'th Dec 2019
One third of this year's Bay Area companies that went public in the past 12 months entered trading on the day after Christmas below their original offering prices.
Hedge Funds Staying Clear Of Atreca, Inc. (NASDAQ:BCEL)
09:54pm, Thursday, 19'th Dec 2019
We can judge whether Atreca, Inc. (NASDAQ:BCEL) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There's no better way to g
JOBS: Communications and Advocacy Manager IRC Uganda
07:41am, Monday, 09'th Dec 2019
Vacancy: Communications and Advocacy Manager IRC Uganda is an organisation working with governments, NGOs and people around the world to find long-term solutions to make access to safe drinking water
Atreca Announces FDA Clearance of Investigational New Drug Application for ATRC-101
01:00pm, Tuesday, 03'rd Dec 2019
Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on the development of novel cancer therapeutics generated through a unique discovery platform based on interrogation of the active
Op Ed: Want to Learn About Bitcoin? Try Contributing a Transcript
06:37pm, Tuesday, 26'th Nov 2019
Contributing to or reading the Bitcoin archive of transcripts maintained by Bryan Bishop (kanzure) can be highly valuable and educational.
Atreca to Present at Two Upcoming Investor Conferences
01:00pm, Thursday, 14'th Nov 2019
REDWOOD CITY, Calif., Nov. 14, 2019 -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of.
Atreca Reports Third Quarter 2019 Financial Results and Recent Corporate Developments
09:05pm, Tuesday, 12'th Nov 2019
REDWOOD CITY, Calif., Nov. 12, 2019 -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of.
Atreca to Highlight ATRC-101 Preclinical Data at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting
01:00pm, Tuesday, 05'th Nov 2019
REDWOOD CITY, Calif., Nov. 05, 2019 -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of.
Common IRS Where's My Refund Questions
07:15am, Tuesday, 29'th Oct 2019
Our FAQ of the most common IRS Where's My Refund Questions, Errors, Comments, Concerns, and more.
The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout
12:14pm, Friday, 11'th Oct 2019
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Oct. 10.) The Medicines Company (NASDAQ: MDCO ) Ra
Do Institutions Own Shares In Atreca, Inc. (NASDAQ:BCEL)?
01:19pm, Thursday, 19'th Sep 2019
Every investor in Atreca, Inc. (NASDAQ:BCEL) should be aware of the most powerful shareholder groups. Institutions...
